Natural adaptive immunity to high risk human papillomavirus (HR HPV) study

Natural adaptive immunity to high risk human papillomavirus (HR HPV) study

Are you interested in taking part in a clinical study that aims to find out how the immune system clears HR HPV, the viruses that cause cervical cancer?

We are looking for women aged 16-24 years who are in good health.

If you choose to take part, we will ask you to attend a maximum of 4 study visits over 1 year. You would be required to give a blood sample and provide a vaginal self-sample at each visit.

The study is taking place at the University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, Headington, Oxford, OX3 7LE.

You will be compensated for your time and for the additional travelling costs to and from the hospital.

A decision to participate/not participate in this study will not impact any clinical care you may receive in this clinic.

If you are interested, please contact the research team on